Call 999 or go to A&E for emergencies
Reported Effects Glycemic control: As an adjunct to insulin, pramlintide produced a modest HbA1c reduction (on the order of a few tenths of a percentage point) versus placebo over 52 weeks in both type 1 and type 2 diabetes [3] [4]
Janna Goldfeld, PA-C Janna Goldfeld, PA-C, is a board-certified Physician Assistant with more than 20 years of clinical experience in primary care, medical weight loss, and telehealth wellness support
Between 1997 and 1999, the FDA received more than 140 reports of adverse events associated with the use of dietary supplements containing ephedra alkaloids
This documentation converts subjective impressions into objective evidence, facilitating collaboration for treatment optimization
Global epidemiology of hyperthyroidism and hypothyroidism